| scholarly article | Q13442814 |
| editorial | Q871232 |
| P2093 | author name string | Hyung Joon Yim | |
| P2860 | cites work | Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings. | Q50997726 |
| Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort study | Q58097173 | ||
| Entecavir plus adefovir combination treatment for chronic hepatitis B patients after failure of nucleoside/nucleotide analogues | Q83301450 | ||
| Adding adefovir vs. switching to entecavir for lamivudine-resistant chronic hepatitis B (ACE study): a 2-year follow-up randomized controlled trial | Q34538293 | ||
| Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strains | Q34596639 | ||
| Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients | Q34948124 | ||
| Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy | Q36181175 | ||
| GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees | Q36950984 | ||
| The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy | Q37097615 | ||
| Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade | Q37229851 | ||
| Tenofovir-based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir | Q40940597 | ||
| Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B. | Q40958942 | ||
| Entecavir plus tenofovir combination therapy in patients with multidrug-resistant chronic hepatitis B: results of a multicentre, prospective study. | Q40967783 | ||
| Prediction of virologic response to tenofovir mono-rescue therapy for multidrug resistant chronic hepatitis B. | Q41148991 | ||
| Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial. | Q41175515 | ||
| Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial. | Q41538789 | ||
| No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B. | Q42277100 | ||
| Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. | Q44709445 | ||
| Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B. | Q45023133 | ||
| Evolution of multi-drug resistant hepatitis B virus during sequential therapy | Q45412758 | ||
| Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. | Q46217486 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | tenofovir | Q155954 |
| P304 | page(s) | 238-240 | |
| P577 | publication date | 2016-06-30 | |
| P1433 | published in | Clinical and molecular hepatology | Q26853927 |
| P1476 | title | Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B? | |
| P478 | volume | 22 |
| Q48265626 | Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir. | cites work | P2860 |
Search more.